Testing of Ebola Vaccine Suspended

ebola health worker
A vaccine may be the only effective measure in controlling the Ebola outbreak in West Africa, which has claimed 6,000 lives so far. (CBN News)

Testing of an Ebola vaccine has been suspended until Jan. 5 after four patients given the drug in a trial complained of joint pain in their hands and feet.

A spokesperson close to the trials said checks are being conducted to make sure the symptoms are "benign and temporary."

Meanwhile, the delay is not worrying scientists, who say suspending trials is common in human drug testing.

"It's not a setback, not at all," Marie-Paule Kieny, vaccine expert at the World Health Organization, told reporters in Geneva.

She explained that the delay to the trial would allow time to see how widespread the problems are, but the trial should then be able to continue as originally planned.

Scientists are racing to approve a vaccine by June. A vaccine may be the only effective measure in controlling the Ebola outbreak in West Africa, which has claimed 6,000 lives so far. 

Aid efforts continue, but the lack of adequate education and medical facilities is making the Ebola outbreak nearly impossible to contain.  

The symptoms reported by volunteers are from a study being conducted in Geneva of an Ebola vaccine licensed by the pharmaceutical company Merck. 

"They are all fine and being monitored regularly by the medical team leading the study," a hospital spokesperson in Geneva said.

Meanwhile, another Ebola vaccine, developed by the pharmaceutical company GlaxoSmithKline is being tested on humans in Lausanne, Switzerland, and is progressing without major incident. 

Professor Blaise Genton, who is leading the GSK trial of 120 volunteers in Lausanne, said the results so far are "satisfactory."

"General symptoms such as fever might be slightly more frequent," he commented, "though no serious adverse event has been observed so far."

The first results of the Lausanne hospital's trial of the GSK vaccine and whether it provides immunity against the virus are expected by the end of December.

Once an Ebola vaccine is approved for mass distribution it can be implemented. GAVI, the global vaccines alliance, pledged $300 million on Thursday to buy Ebola vaccines.


To contact us or to submit an article, click here.


Get Charisma's best content delivered right to your inbox! Never miss a big news story again. Click here to subscribe to the Charisma News newsletter.

Five ways to deepen your relationship with God, increase your faith and save money!

  • Deepen Your Relationship with God with a FREE eCourse: Click Here to view all of our free e-Courses. Favorite topics include Fear, Forgiveness, Holy Spirit, Supernatural, and How to Hear God.
  • Super Discounts and Close-Out Specials: Click Here to view all our bundles and close-out specials and save up to 86%! Prayer, Holy Spirit, Anointing, the Supernatural and more.
  • God Wants to Anoint Women Now: Rise up and enter the anointing of Deborah, Anna, Esther, Ruth and Hannah. You were called to go higher. Click Here to learn more.
  • Change Your Atmosphere and Circumstances Through Prayer! John Eckhardt's prayer bundle gives you six powerful books to help you pray and change any situation. Click Here.
  • HUGE Bible Sale!: Click Here to save up to 50% off a great selection of Bibles. Plus, get a free gift with each order!

Subscription Special: Subscribe to Charisma for Only $24.97 and get a free gift. With your subscription, you'll receive Born For Significance by best-selling author Bill Johnson. View Offer

Attention Pastors and Leaders: Leadership training and development are crucial for success. Enroll in a FREE 1-hour leadership mini-course by Dr. Mark Rutland. View Details

Charisma News - Informing believers with news from a Spirit-filled perspective